Cancer News and Research

Latest Cancer News and Research

Increased Sirt1 expression protects against neurodegeneration in HD mouse model

Treatment that increases brain levels of an important regulatory enzyme may slow the loss of brain cells that characterizes Huntington's disease (HD) and other neurodegenerative disorders.

19 Dec 2011

Link between malaria and salmonella infections

The link between malaria and salmonella infections has been explained for the first time, opening the way to more effective treatments.

19 Dec 2011

HPV test outshines Pap smears for detection of early cervical cancers

A new trial involving nearly 40,000 women in the Netherlands showed that testing for the human papillomavirus, or HPV allowed doctors to detect abnormal cervical cells earlier and prevent more cases of cervical cancer than administering pap smears alone.

18 Dec 2011

Tanning beds raise risk of skin cancer – kids need to be barred

The issue regarding the banning of under-18s from tanning beds has come up again. Manitoba MP James Bezan is pushing for it. The Conservative MP introduced a private members’ bill Thursday that would bar anyone under the age of 18 from using a tanning bed, as well as require tanning salons to improve the warning signs and labels on and around their machines.

18 Dec 2011

Baxter receives FDA approval for ADVATE to prevent hemophilia A

Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ADVATE [Antihemophilic Factor (Recombinant) Plasma/Albumin Free Method] for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A.

From Baxter International Inc. 17 Dec 2011

Combination of bevacizumab and chemoradiation safe, effective for nasopharyngeal carcinoma

The trial conducted by the Radiation Therapy Oncology Group (RTOG) shows the feasibility to deliver bevacizumab to the current chemoradiation standard without any apparent increased adverse side effects.

17 Dec 2011

Enrollment complete in ThromboGenics, BioInvent TB-402 Phase IIb trial on VTE

ThromboGenics NV and co-development partner BioInvent International announce today that they have completed the enrolment of a 632-patient Phase IIb trial with their novel long-acting anticoagulant TB-402 for the prophylaxis of venous thromboembolism (VTE) after total hip surgery. The trial has recruited patients from 36 centers across Europe.

17 Dec 2011

President Obama honors mentoring program for minority girls in science and health

Teresa Woodruff, the Thomas J. Watkins Professor of Obstetrics and Gynecology at Northwestern University Feinberg School of Medicine, received the prestigious Presidential Award for Excellence in Science, Mathematics and Engineering Mentoring at the White House from President Barack Obama Monday, Dec. 12.

17 Dec 2011

Researchers discover miR-520 blocks cancer-promoting signaling pathway

MicroRNAs or miRNAs are tiny RNA molecules that have only about 20 nucleotides and do not code for proteins. They regulate many important processes in cells by binding to target messenger RNAs - the instructions for protein production -, thus blocking production of the respective protein. In cancer, the production of some miRNAs is often reduced or amplified. This particularly affects miRNAs that regulate the activity of cancer-promoting genes.

17 Dec 2011

New procedure helps reconstruct cricoid cartilage in a cancer patient

When Sherry Wittenberg was diagnosed with a rare cancer in the cricoid cartilage of her larynx, doctors told her the only way to treat the condition was to remove her voice box. The operation would leave her unable to speak normally and would require her to breathe through a hole in her neck for the rest of her life.

17 Dec 2011

NYC Council Member celebrates re-launch of Einstein's Gruss MRRC

At a morning ceremony today, New York City Council Member James Vacca, along with administrators and faculty members of Albert Einstein College of Medicine of Yeshiva University, celebrated the re-launch of Einstein's Gruss Magnetic Resonance Research Center.

17 Dec 2011

Scientists devise a way to reduce side effects of lung cancer therapy

Scientists may have a way to double the efficacy and reduce the side effects of radiation therapy.

17 Dec 2011

If misused, popular noisy toys may permanently damage children's hearing

While Road Rippers Lightning Rods, Let's Rock Elmo and the I Am T-Pain musical microphone might be sought-after gifts this holiday season, parents should ensure that their children don't risk permanent hearing damage by misusing them.

17 Dec 2011

Washington state's tobacco prevention and cessation programs reduce health care costs

The following is a statement by Matthew L. Myers, President, Campaign for Tobacco-Free Kids: A study published Thursday by the American Journal of Public Health provides some of the strongest evidence yet that tobacco prevention and cessation programs not only reduce smoking and save lives, but also save money by reducing tobacco-related health care costs.

17 Dec 2011

Researchers demonstrate laser transmission spectroscopy

A team of researchers from the University of Notre Dame have demonstrated a novel DNA detection method that could prove suitable for many real-world applications.

17 Dec 2011

Microvascular stamp stimulates, directs blood vessel growth on wound surface

Researchers have developed a bandage that stimulates and directs blood vessel growth on the surface of a wound. The bandage, called a "microvascular stamp," contains living cells that deliver growth factors to damaged tissues in a defined pattern. After a week, the pattern of the stamp "is written in blood vessels," the researchers report.

16 Dec 2011

Soligenix secures Harvard option rights to initiate anthrax vaccine development program

Soligenix, Inc., a development stage biopharmaceutical company, announced today that it has initiated a next generation anthrax vaccine development program pursuant to a field-exclusive option agreement with Harvard University to negotiate a license under patent rights that cover prophylactic uses of a modified anthrax toxin protein.

16 Dec 2011

Researchers identify gene responsible for EMT transformation

Researchers at the Institute for Research in Biomedicine (IRB Barcelona) have identified the gene GATA 6 as responsible for epithelial cells -which group together and are static- losing adhesion and moving towards a new site.

16 Dec 2011

Study aims to reduce mortality disparities by education

A study in the December issue of the American Sociological Review has brought new understanding as to why death rates for less educated middle aged adults are much higher than for their more educated peers despite increased awareness and treatments aimed at reducing health disparities.

16 Dec 2011

IASLC takes proactive role in advancing lung cancer screening forward

The International Association for the Study of Lung Cancer (IASLC) has taken a proactive role in advancing discussions with the international lung cancer community on how we should take lung cancer screening forward.

16 Dec 2011